MYnd Analytics Inc (MYND) Director John Pappajohn Purchases 100,000 Shares

MYnd Analytics Inc (NASDAQ:MYND) Director John Pappajohn purchased 100,000 shares of the company’s stock in a transaction that occurred on Thursday, March 14th. The stock was acquired at an average cost of $1.68 per share, with a total value of $168,000.00. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink.

MYND stock traded down $0.03 on Friday, reaching $1.57. The company’s stock had a trading volume of 74,645 shares, compared to its average volume of 260,189. MYnd Analytics Inc has a 12-month low of $0.62 and a 12-month high of $4.08. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.54.

MYnd Analytics (NASDAQ:MYND) last announced its quarterly earnings results on Tuesday, December 11th. The company reported ($0.20) EPS for the quarter. The business had revenue of $0.34 million during the quarter. MYnd Analytics had a negative return on equity of 430.80% and a negative net margin of 589.07%.

Separately, Maxim Group reaffirmed a “buy” rating and issued a $5.00 price target on shares of MYnd Analytics in a research note on Thursday, December 13th.

ILLEGAL ACTIVITY NOTICE: This story was posted by WKRB News and is owned by of WKRB News. If you are viewing this story on another publication, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The correct version of this story can be viewed at https://www.wkrb13.com/2019/03/15/mynd-analytics-inc-mynd-director-john-pappajohn-purchases-100000-shares.html.

About MYnd Analytics

MYnd Analytics, Inc operates as a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. It provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioural disorders, includes depression, anxiety, bipolar disorder, post-traumatic stress disorder, and other non-psychotic disorders.

See Also: Special Dividends

Receive News & Ratings for MYnd Analytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYnd Analytics and related companies with MarketBeat.com's FREE daily email newsletter.